Systems Therapeutics for Lung Cancer

Our new work on systems biology of lung cancer has proposed a precision oncology platform for treatment pf NSCLC by allupurinol and a JAK2 inhibitor based on gene signatures.

This work is now available on bioRxiv.

Featured Posts
Posts are coming soon
Stay tuned...
Recent Posts
Archive
Search By Tags